Antioxidant activity study and tyrosinase inhibitory study of Entada spiralis Ridl. by Syed Mohamad, Syarifah Nurul Akilah et al.





15th -16th August 2016
INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA, KUANTAN

 ICIP 20162 nd
INTERNATIONAL CONFERENCE ON INDUSTRIAL PHARMACY
Generics & Biosimilars
TABLE OF CONTENTS     
1
Conference Organizer     2
Sponsors         3
Foreword        4
Pre-Conference Programme    6
Conference Programme     7
Plenary Sessions       10
Invited Sessions       18
Pre-Conference Session     32
List of Oral Presentations     34
List of Poster Presentations     38
Organizing Committee     41
Advertisements       42
Acknowledgement      48    
 ICIP 20162 nd






Kulliyyah of Pharmacy, International Islamic University Malaysia
Supported by
Malaysian Pharmaceutical Society
 ICIP 20162 nd
INTERNATIONAL CONFERENCE ON INDUSTRIAL PHARMACY
Generics & Biosimilars
SPONSORS     
3
RGS Corporation Sdn Bhd.
Chemical Company of Malaysia (CCM) Berhad
 
Kotra Pharma (M) Sdn Bhd




Style Fusion Sdn Bhd
First Base Laboratories Sdn Bhd
Special thanks to our supportive sponsors
 ICIP 20162 nd
INTERNATIONAL CONFERENCE ON INDUSTRIAL PHARMACY
Generics & Biosimilars
FOREWORD     
In the Name of Allah, The Most Gracious, The Most Merciful
In Portugal, the generic market grew from almost non-existent
in 2000 to 30% in volume with a corresponding 23% growth in
value in 2011 . 
The contribution of India to the production of generic drug is
definitely an understatement. It was reported by Doctors Without 
Borders that 80% of the drugs they used for the treatment of HIV/AIDS are generic produced
by Indian companies .  Other Indian generic drugs used are for the treatment of TB, 
malaria and infectious diseases.
Despite the relatively affluent Japanese, the government is strategising to minimise medical
expenditures by substituting innovator products with generic drugs . The target is to have
60% share by volume comes March 2018. This strategy involves the revision of pricing
scheme that intends to lower the generic drug price by 50% compared to originator.
Worldwide, the pharmaceutical market revenue increases from USD427.6 billion in
2002 to more than a trillion in 2014 . If the Japanese target is something to be reckoned
with, this is a strong driving force for the growth of the generic and biosimilar
pharmaceutical industry. 
In reflection, if the Japanese who are wealthy enough has a strategy to reduce cost by
using generic drugs, the motivation should be even stronger with developing countries 
in Asia including the Indian sub-continent and Africa. We can expect increasing number 
of manufacturers and manufacturers increasing their capacity. With these activities, 
quality could be forsaken if regulatory bodies could not keep up with the escalating 
volume of products.  Best practices in industrial pharmacy must be encouraged, 
data integrity is sanctified and basic requirements must be adhered.
Most importantly however, is how we react to socio-economic challenges. In times 
of economic tribulation throughout the world, we are also put to tasks with infectious
diseases that call for new therapies and vaccines. As we have witnessed, the Zika
virus and the Ebola virus for instance, struck nations that are trying to climb the
economic ladder. These are nations having people in the income poverty category 
and perhaps a few in the extreme poverty category of sustaining with less than
USD1 a day . To these people, quality of life is an alien concept what more
sophisticated medicines.
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As educators, scientists, industrialist, regulators and responsible people who contribute to 
industrial pharmacy, we must see the industry beyond stature and monetary gains. It is 
undeniably a social issue. Medicines should reach all shores and never discriminatory in 
any way. It is a sacred obligation to save life, intellect and progeny. While generics and 
biosimilars should be encouraged to reduce costs, over prescription, ineffective 
patient-counselling resulting in wastes and unethical practices downstream are real issues, 
which must be dealt with, that defeat the purpose of having generics and biosimilars in the 
first place.
Thus it has been said. 
On behalf of the organising committee,
     “Welcome to the 2nd International Conference on Industrial Pharmacy.” 
We hope that all of us have a wonderful time meeting each other, sharing our ideas and 
contribute to the body of knowledge passionately and wisely for the sake of humanity.
Smile and you will get a smile in return!
Thank you to our invited speakers and honourable guests for your participation. 
We value your presence and finding time to be with us in spite of your other commitments. 
Let us together shape industrial pharmacy as an ethical, a socially-sensitive and a 
responsible industry. 
And we hope to see you again in 2018.
Thank you to all my lovely friends who have unrelentingly, tirelessly and indefatigably worked 
to organise the conference. May Our Creator The Most Gracious grant you with more energy
and everything good in this World and in the Hereafter. We appreciate very much the support
given by the university and our partners in research and education.
Pisang emas bawa belayar, 
masak sebiji di dalam peti.
Hutang emas boleh dibayar
hutang budi dibawa mati.




FOREWORD     
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PRE-CONFERENCE
PROGRAMME     
PRE-CONFERENCE WORKSHOP
14TH AUGUST 2016 | SUNDAY
Instructor: Puan Rohani Mohammad (Affiliate Manager ISPE Malaysia)
 GMP IN QC LAB









GMP Audit findings in QC Laboratory
Common Audit findings in QC Laboratory
Q&A Session
1300 Lunch - End of Session
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CONFERENCE
PROGRAMME     
CONFERENCE DAY 1 
15TH AUGUST 2016 | MONDAY
0830-0900
0900-0915
Grand Hall, Level 1
Registration
Breakfast & Poster Prep
Opening Ceremony
Recitation of Quran
Bro Muhammad Badri Abdul Kudos





The Development of the Malaysian 
Generic Industry - A Practitioners’ Perspective 










Bringing Research to Industry: 
Environmentally Benign Commercialization of 
Supercritical Fluid Technology
Prof. Kenji Mishima 




Grand Hall, Level 1
Invited Session 1
Curcumin-Loaded Nanoemulsion for 
Pharmaceutical Applications   
Dr. Heni Rachmawati  
Associate Professor - Pharmaceutics 
Bandung Institute of Technology, Indonesia




1430-1500 Invited Session 2
The Biotechnology Industry – Past, 
Present and Future
Ms. Michelle Peake 




1235-1300 Poster Presentation 2 Grand Hall, Level 1
0915-0930 Banquet Hall,
Ground Floor
Tea Break & Networking
Welcoming  Address
Prof Dato’ Dr Tariq Abdul Razak 
Campus Director, IIUM Kuantan
1000-1030
OCD Staircase
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CONFERENCE
PROGRAMME     
1500-1530     
1530-1600
Invited Session 3
Pharmaceutical Industry Outlook in Korea   




Clinical Drug Design 
Prof. Basavaraj K Nanjwade
Professor
Department of Pharmacy Practice
The Oxford College of Pharmacy, India








Dr Siti Hadijah Shamsudin 
Dean, Kulliyyah of Pharmacy, IIUM
Banquet Hall,
Ground Floor
Grand Hall, Level 1
Grand Hall, Level 1
Banquet Hall,
Ground Floor
Banquet Hall, Ground Floor
Seminar Room 2, Ground Floor
Seminar Room 3, Ground Floor
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Plenary Session 3
Industrial Pharmacy - The Pharmacy Profession's Dilemma? 










Challenges and Opportunities in the 
Pharmaceutical Biosimilar Industry
Dr Abdul Manaf Mohd Radzi 
???????????????? ?????
University-Industry Partnership, 




CONFERENCE DAY 2 
16TH AUGUST 2016 | TUESDAY
Registration & Breakfast Grand Hall, Level 1
Grand Hall, Level 1
1020- 11  10
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1110 - 1140     
1140 - 1210
Invited Session 5
Proteins and Enzymes in Drug Delivery 
Prof. Hamzah Salleh 
Professor - Biotechnology Engineering, 
International Islamic University Malaysia
Invited Session 6
????? ???????????????????????? ???????????????????????
for Pharmaceutical Industries   
Ir. Dr. Nizamil Fairuz bin Yahya   
Managing Consultant 
PharmEng Technology, Malaysia







Closing Ceremony & 
Presentation of Awards   
Dr Juliana Jaffri
Head, Department of Pharmaceutical Technology, 
Kulliyyah of Pharmacy, IIUM
Banquet Hall,
Ground Floor
Grand Hall, Level 1
 Grand Hall, Level 1
Afternoon Tea - Conference Ends




Banquet Hall, Ground Floor
Seminar Room 2, Ground Floor
Seminar Room 3, Ground Floor
1700
1210 - 1240 Invited Session 7
Replacement of Toxic Solvents Used in the 
Pharmaceutical Industry with Safe and 
Renewable Mixed-Solvents 
Prof. Richard Smith  




1500 - 1600 Parallel Session 7
Parallel Session 8
Parallel Session 9
Banquet Hall, Ground Floor
Seminar Room 2, Ground Floor
Seminar Room 3, Ground Floor
Grand Hall, Level 1
CONFERENCE
PROGRAMME     
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Head of Composite Material Research Center
Department of Chemical Engineering,
Fukuoka University, Japan 
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Bringing Research to Industry: 
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Industrial Pharmacy - The Pharmacy Profession's Dilemma?
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Challenges and Opportunities in the Pharmaceutical Biosimilar Industry
Abdul Manaf Mohd Radzi
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Curcumin-Loaded Nanoemulsion for Pharmaceutical Applications
Heni Rachmawati1, Dahlia Permatasari1, Miranti A.Novel1, Irene S. Soraya1, 
Risya M. Nisa1, Guntur Berlian2, Olivia M. Tandrasasmita2, Annisa Rahma1, Catur Riani1, 
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Ms Michelle Peake 
General Manager and Principal Biotech Consultant
Synertech Asia
??? ??????????????????????? ??????????????????????????????????????????????????????????????????????
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Mr Jae Hwang 
????????????????????
JH Bio System, Korea
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Professor Dr. Hamzah Salleh
Department of Biotechnology Engineering
Kulliyyah of Engineering
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Ir. Dr. Nizamil Fairuz Yahya, 
Director & Managing Consultant
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10 Simple Steps for Equipment Qualification Compliance 
for Pharmaceutical Industries
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Professor Richard L. Smith, Jr. 
Graduate School of Environmental and
??????????????????????????????????????
Department of Chemical Engineering.
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Replacement of Toxic Solvents Used in the 
Pharmaceutical Industry with Safe and Renewable Mixed-Solvents
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In this session, the participants will be introduced to the basic requirements that any 
regulated QC laboratory will need to understand and follow.  Each basic element in 
the applicable standards will be discussed to give an overview of the overall requirements 
to ensure compliance to basic GMP requirements for QC laboratory.  This session will also 
introduce the concept of Good (QC) Laboratory Practice.
SESSION 2
Here, the focus is on the auditing for compliance to the requirements of GMP in QC 
laboratory.  The concept of auditing will be explained together with brief descriptions 
of the audit processes.  The roles of the auditees and the auditors will be discussed 
to give some understanding of what is required when conducting an audit.
SESSION 3
The third session will consist mainly the sharing of some common audit findings in 
QC laboratory.  This will show how the requirements learnt in Session 1 and the 
auditing processes learnt in session 2 culminate into the audit results which is the 
audit findings.  By sharing the common audit findings, the participants are warned 
of the most common pitfalls during daily QC operations and thus, will take care to 
avoid the usual mistakes when performing their daily QC tasks.
Synopsis
33
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Parallel Session 1 (Product Development, Scale Up and Manufacturing Processes)
Time : 1600-1700 (15th August 2016)
Venue : Banquet Hall, Ground Floor
Moderator: Dr. Juliana Md. Jaffri
ID ????? ??????? ?? ?
Budget Impact Analysis on the Introduction of 
Biosimilar Rituximab and Trastuzumab into Malaysia 
Market.
Norazrina Pakiman46
Slow release of ibuprofen encapsulated in gellan
gum hydrogel for dressing application. Khairul Anuar Mat Amin
Nanoencapsulation of Curcuma zedoaria /Allium 





Parallel Session 2 (Regulatory Affairs and Compliance)
Time : 1600-1700 (15th August 2016)
Venue : Seminar Room 2, Ground Floor
Moderator: Dr. Che Suraya Haji Mohd Zin
ID ????? ??????? ?? ?
Perception of Malaysian Community Pharmacists 
towards the Impacts of Generic Substitution on 
Community Pharmacies Profits: A Pilot Study
Tarek Elsayed10
The relationship of work motivation to production 
department productivity of PT. Nufarindo 
Pharmaceutical.
Indra Putra Taufani
Pharmacists Perception to the Introduction of the 
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Parallel Session 3 (Biopharmaceuticals and Biotechnology)
Time : 1600-1700 (15th August 2016)
Venue : Seminar Room 3, Ground Floor.
Moderator: Associate Professor Dr. Muhammad Taher   
ID ????? ??????? ?? ?
Screening and selection of potentially viable 
probiotics lactobacilli and evaluation of tolerance 
in acid and bile salt
Hassan Pyar
Approaches to modify the nature of xanthan gum and 





Parallel Session 4 (Product Development, Scale Up and Manufacturing Processes)
Time : 1400-1500 (16th August 2016)
Venue : Banquet Hall, Ground Floor
Moderator: Professor Zaidul Islam Sarker
ID ????? ???????? ?? ?
Physicochemical stability of Sonchus arvensis L. 
and Lumbricus rubellus tablets
Fitra Romadhonsyah25
Optimization of the Formulation for Ibuprofen-loaded 
Self-Nanoemulsifying Drug Delivery System Hannie Fitriani
In vitro Analysis of Total Phenolic Contents, Flavonoids 
and Free Radical Scavenging Activities of Black 
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Parallel Session 5 (Analytical Method Development & Validation)
Time : 1400-1500 (16th August 2016)
Venue : Seminar Room 2, Ground Floor.
Moderator: Dr. Abd  Almonem Doolaanea    
ID ????? ???????? ?? ?
Development and validation of a LC- MS/MS method 
for simultaneous quantitation of telmisartan and 
pioglitazone in rat plasma
Pinaki Sengupta11
Development of a Liquid Chromatography Mass 
Spectrometry (LCMS) Method for Simultaneous 
Determination of Phosphodiesterase-5 Inhibitors
Nur Baizura Bujang
Analytical Method Validation for Pharmaceutical Industries Nizamil Fairuz Yahya
20
19
Parallel Session 6 (Product Development, Scale Up and Manufacturing Processes)
Time : 1400-1500 (16th August 2016)
Venue : Seminar Room 3, Ground Floor
Moderator: Dr. Bappaditya Chatterjee
ID ????? ???????? ?? ?
Subcritical carbon dioxide extraction of 
????????????????????????? stem bark and the 
extract’s potential as an anti-dermal infection agent 
Anis Fadhlina 
Izyani Awang08
Enriched extracts of antidiabetic compounds from neglected 
weed M. pudica using supercritical and subcritical carbon 
dioxide extractions and the corresponding in vitro study for 
diabetes mellitus
Tasnuva Sarwar Tunna
Optimization and formulation of glimepiride self-nano
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Parallel Session 7 (Biopharmaceuticals and Biotechnology)
Time : 1500-1600 (16th August 2016)
Venue : Banquet Hall, Ground Floor.
Moderator: Bro Muhammad Badri Abdul Kudos   
ID ????? ???????? ?? ?
23 Anti hyperlipidemic activity of Vigna Mung Linn Anjana Male
Arborinine from Glycosmis pentaphylla (retz.) DC. induces 
apoptosis through activation of caspase-3/7 in Human 





Parallel Session 8 (Product Development, Scale Up and Manufacturing Processes)
Time : 1500-1600 (16th August 2016)
Venue : Seminar Room 2, Ground Floor
Moderator: Dr. Hazrina Ab Hadi
ID ????? ???????? ?? ?
Compatibility study between paracetamol and 





Microbiology stability of Sonchus arvensis L. 
and Lumbricus rubellus tablets Mira Amaliasari Sitorus
Effect of process variables on the preparation of BSA 
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Poster Presentation Session 1
Time : 1210-1235 (15th August 2016)
Venue : Grand Hall, 1st Floor.   
ID ????? ????????? ?? ?
Process validation for pilot-scale production of 
betamethasone 17-valerate emulsions using palm 
olein as topical drug delivery vehicle
Thazin Win03
1210-1235
Characterization and stability evaluation of melt 
mixed solid dispersed nisoldipine with improved 
solubility
May Kyaw Oo




Tc99m DTPA: a tool in dynamic renal imaging33 Mohamad Shahrir 
Abdul Rahim
38
Swelling index, gel fraction, thermal and rheological 
properties of Centella asiatica hydrogel
Afnan Ahmed
Effect of neutron irradiation on the physicochemical 
properties of Naproxen Sodium
Mohamed Awang44
54 Development and characterization of topical 
analgesic ointment-from lab to production scale
Noor Adibah Md Adib
Fabrication of Gentamicin and N. sativa oil loaded PLGA 
Microspheres and The Comparison of Extended Release 
Profile Between Powdered and Compressed Forms
Farahidah Mohamed60
Optimization of thymoquinone-plga loaded 




Surface-active proteins in Syzygium aromaticum 
extract for the stabilisation of pal olein-in-water 
emulsion
Kausar Ahmad71
A study on rheological properties of various gelling 




76 Optimization of extraction method to obtain 
chitosan from squid pen Hazrina Hadi
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Poster Presentation Session 2
Time : 1235-1300 (15th August 2016)
Venue : Grand Hall, 1st Floor.   
ID ????? ????????? ?? ?
A review of phytochemical and pharmacological 




Antimicrobial potential of various solvent extracts from 
leaf, stem and root of Anisophyllea disticha Nurul Ashikin Abdul Bari
Antioxidant capacities and phenolic profile of four 






Anticancer properties of thymoquinone and 
dithiocarbamate metal complexes against oral squamous
cell carcinoma HSC-3 and HSC-4 cell lines
34 Wastuti Hidayati Suriyah
35
Antioxidant activity study and tyrosinase inhibitory 
screening of Entada spiralis ridl. leaves
Sharifah Nurul Akilah
Syed Mohamad
Phytochemical profile and free radical scavenging 
activity of Entada spiralis Ridl. stem bark
Fatimah Opeyemi 
Roheem36
37 Anticancer effects of Eurycoma longifolia, Nigella sativa 
and Hibiscus sabdariffa on ovarian cancer cells
'Afif Raihan Abdullah
Isolation and identification of flavonoids from 




Pharmacological activities and comprehensive 
metabolite profiling of Clinacanthus nutans extract and 
fractions.
Md. Ariful Alam50
Development and validation of high performance 
liquid chromatography method for analysis of 
Raloxifene HCL in rat plasma by liquid –liquid extraction
Syed Mahmood55
Cytotoxic study of Knema laurina and Antidesma 
orthogyne extracts on human breast cancer cell line 
MCF-7
Sama N. Shaban61
68 Antioxidant activities of five compounds isolated 
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Poster Presentation Session 3
Time : 1240-1300 (16th August 2016)
Venue : Grand Hall, 1st Floor.   
ID ????? ????????? ?? ?
Cytotoxicity study of newly-synthesized carbonyl thiourea 
derivatives on pathogenic Acanthamoeba and its 
quantitative structure-activity relationship (QSAR) analysis
Maizatul Akma Ibrahim22
Halal meat adipose tissue: a novel sources 
of adiponectin  
Nuraniza Azahari
Phaleria macrocarpa seed as alternative vegetable 





The role of polyamines in growth inhibition induced by 
Momordica charantia and Gynura procumbens in human 
lung adenocarcinoma cells, A549
49 Radiah Abdul Ghani
56
Turning eel oil into gummy candies:  A potential innovative 
nutraceutical product of eel (Anguilla sp.) Desi Rahmawaty
Development and validation of bioanalytical method
for the detection of gliclazide in human plasma.
Mohamed Alaama57
59
Analysis of the influencing factors of gentamicin-N. 




Understanding and perception towards generic medicines 
among final year pharmacy students, International Islamic 
University Malaysian: A quantitative Insight
Shazia Jamshed65
Preparation, characterization and factor effect 
screening of plasmid DNA loaded in PLGA/chitosan/
Nigella sativa oil microparticles
Mohd Fakhrul Radzi  
Mamat 
67
Sensory analysis of texture and appearance lip 
balm containing olive oil
Hazrina Hadi77
Influence of drug:polymer ratio in entrapment of 
salicylic acid into microsponge Hazrina Hadi
78
79 An evaluation of UNIFAC model for the prediction of 
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Summary of the Programme
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